Nanovi APS
Injectable liquid tissue marker for improved radiation precision
This article was originally published in Start Up
Executive Summary
The unavailability of a good fiducial marker for pre-treatment image planning and subsequent image-guided radiotherapy is currently a major obstacle to enhancing radiotherapy standards. Copenhagen, Denmark-based start-up Nanovi APS has developed an injectable, liquid, biomaterials-based tissue marker that promises to improve accuracy in IGRT of several types of cancer, including lung cancer.